Global Head Digital Trials- Global Clinical Operations

Boehringer Ingelheim Pharmaceuticals, Inc.

Passionate about bringing the human element to our modern technologicalworld, after all what is technology if it can’t connect to the most basic need inall of us, catering to our most innate emotion

Mohammed (Mo) Ali, is the global head for digital development, Global Clinical Operations. He is responsible for the operational execution of the digital development strategy within medicine for Boehringer Ingelheim. He is passionate about digital health and is an evangelist for the advocacy of digital solutions within the patient care and drug development paradigm. His mission is help create alongside his industry peers a closed loop system of digital data driven drug development where the voice of the customer – the patient, the caretaker and the HCP takes center stage in ensuring the best point of care solutions are available for every part of the disease management lifecycle. Previously to joining Boehringer Ingelheim, he has held positions with increasing responsibilities within J&J, Novartis, Roche and Fresenius Healthcare. Mr. Ali has a background in pharmacology and lives with his family in NJ.

Latest insights

Fri Mar 13 2020

Did an experimental drug help a U.S. coronavirus patient?

Fri Jan 10 2020

MoneyBall Medicine: Tom Davenport on the Analytics Gap in Healthcare

Wed Dec 18 2019

MoneyBall Medicine – Milind Kamkolkar on Seeing the Forest and the Tr...

Fri Nov 8 2019

Gini Deshpande of NuMedii on Augmented Intelligence for Drug Discovery

Never miss an announcement